Published in Adv Exp Med Biol on January 01, 2008
Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov (2015) 1.90
Myosinopathies: pathology and mechanisms. Acta Neuropathol (2012) 1.29
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev (2015) 1.20
Sparing of muscle mass and function by passive loading in an experimental intensive care unit model. J Physiol (2012) 0.87
Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model. PLoS One (2014) 0.79
Clustering gene expression regulators: new approach to disease subtyping. PLoS One (2014) 0.79
Aspects of physical medicine and rehabilitation in the treatment of deconditioned patients in the acute care setting: the role of skeletal muscle. Wien Med Wochenschr (2016) 0.77
Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care. Crit Care (2016) 0.77
Statistical insights into major human muscular diseases. Hum Mol Genet (2014) 0.75